1.09
-0.03(-2.68%)
Currency In USD
| Previous Close | 1.12 |
| Open | 1.13 |
| Day High | 1.16 |
| Day Low | 1.07 |
| 52-Week High | 3.08 |
| 52-Week Low | 0.87 |
| Volume | 60,253 |
| Average Volume | 182,448 |
| Market Cap | 43.94M |
| PE | -1.31 |
| EPS | -0.83 |
| Moving Average 50 Days | 1.17 |
| Moving Average 200 Days | 1.44 |
| Change | -0.03 |
If you invested $1000 in TELA Bio, Inc. (TELA) since IPO date, it would be worth $81.65 as of January 08, 2026 at a share price of $1.09. Whereas If you bought $1000 worth of TELA Bio, Inc. (TELA) shares 5 years ago, it would be worth $69.56 as of January 08, 2026 at a share price of $1.09.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
TELA Bio to Participate in the Piper Sandler 37th Annual Healthcare Conference
GlobeNewswire Inc.
Nov 19, 2025 1:30 PM GMT
MALVERN, Pa., Nov. 19, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will participate in
TELA Bio Announces Pricing of $13.0 Million Underwritten Registered Direct Offering of Common Stock and Pre-Funded Warrants
GlobeNewswire Inc.
Nov 13, 2025 9:21 PM GMT
MALVERN, Pa., Nov. 13, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced the pricing of an underwritten registered d
TELA Bio to Announce Third Quarter 2025 Financial Results
GlobeNewswire Inc.
Nov 04, 2025 1:30 PM GMT
MALVERN, Pa., Nov. 04, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will re